{
    "code": "51059663",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51059663",
    "time": "2021-06-18 03:15:32",
    "許可證字號": "衛部藥製字第059663號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/04\/10",
    "發證日期": "106\/04\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105966301",
    "中文品名": "瑞伏駭膠囊15毫克",
    "英文品名": "Leavdo Capsules 15mg",
    "適應症": "Lenalidomide與dexamethasone合併使用可治療先前尚未接受過任何治療且不適合移植之多發性骨髓瘤病人。\r\nLenalidomide單一療法適用於做為已接受自體造血幹細胞移植之新診斷多發性骨髓瘤成年病人的維持治療用藥。\r\nLenalidomide與dexamethasone合併使用可治療先前已接受至少一種治療失敗之多發性骨髓瘤(multiple myeloma, MM)病人。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000粒PTP 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LENALIDOMIDE",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "6201125122  台灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "1406804300  臺灣東洋藥品工業股份有限公司中壢廠",
            "製造廠廠址": "桃園市中壢區中華路一段８３８號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008200300",
            "成分名稱": "LENALIDOMIDE",
            "含量描述": "",
            "含量": "15.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "010596630004 裸膠囊外觀-106-05-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "瑞伏駭膠囊15毫克(衛部藥製059663號)_仿單-110-05-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=013&Type=9"
        },
        {
            "title": "059663Leavdo_依原廠2020仿單更新_完稿_20200917-109-10-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=012&Type=9"
        },
        {
            "title": "瑞伏駭膠囊15毫克彩盒-2CT01283(A01)-1212-108-01-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=008&Type=8"
        },
        {
            "title": "1070104-台灣東洋-瑞伏駭膠囊15毫克膠囊(Leavdo)PTP改版-174-108-01-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=007&Type=8"
        },
        {
            "title": "07.010596630003 外盒-106-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=006&Type=8"
        },
        {
            "title": "07.010596630002 鋁箔(樣稿)-106-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=005&Type=8"
        },
        {
            "title": "07.010596630002 鋁箔(實體)-106-10-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059663&Seq=004&Type=8"
        }
    ]
}